Mast cell tumors in dogs can be shrunk through several proven approaches, and the right one depends on the tumor’s grade, location, and whether it has spread. Options range from a simple steroid course that can reduce tumor volume by 60% or more within two weeks, to targeted injections, oral medications, chemotherapy, and radiation. Most dogs respond well to at least one of these treatments.
Why Tumor Grade Matters First
Before choosing a treatment, your veterinarian needs to know what you’re dealing with. A biopsy or fine needle aspirate tells you the tumor’s grade, which is the single biggest factor in deciding how aggressively to treat it. Veterinary pathologists use two grading systems: a three-tier system (grades I, II, and III) and a simpler two-tier system (low-grade or high-grade). Low-grade and grade I/II tumors tend to grow slowly and respond well to treatment. High-grade and grade III tumors are more aggressive, more likely to spread, and typically need a combination of therapies.
Your vet may also recommend testing the tumor for specific genetic mutations that affect how it responds to certain drugs. This information helps guide whether targeted oral therapies will be effective for your dog’s particular tumor.
Prednisone: The Fastest Way to Shrink a Tumor
Prednisone, a common corticosteroid, is often the first tool veterinarians reach for because it works quickly and is inexpensive. At a standard dose of 1 mg per kilogram of body weight daily, prednisone can produce a median 63% decrease in tumor volume. In one study, about 70% of dogs showed a measurable response within a median of just 9 days. Another found that 87% of grade II tumors shrank by at least 25%, with a median reduction of 81%.
Higher doses (up to 2.2 mg/kg) don’t appear to work significantly better than the standard dose, but they do cause more side effects like increased thirst, urination, and appetite. Prednisone alone isn’t typically a long-term solution for eliminating tumors, but it’s extremely useful for rapidly reducing tumor size before surgery or while waiting for other treatments to begin.
Stelfonta: A Direct Injection That Destroys the Tumor
Stelfonta is the first and only FDA-approved injection given directly into the tumor itself. It works on non-metastatic mast cell tumors in or just under the skin. For subcutaneous tumors, it’s approved for use on the lower legs only, below the elbow or hock.
In the clinical trial of 118 dogs, 75% of treated dogs achieved complete remission after a single injection, assessed about a month later. Dogs that didn’t fully respond the first time could receive a second injection; 44% of those retreated dogs then had their tumor disappear completely. The treatment causes a controlled wound at the injection site as the tumor tissue breaks down and sloughs off, so your dog will need wound care for several weeks afterward. But for eligible tumors, it offers a strong alternative to surgery.
Targeted Oral Medication
Toceranib phosphate (sold as Palladia) is an oral medication that blocks the signals tumor cells use to grow and recruit blood supply. Used alone, it produces a response rate of about 42%. When combined with other chemotherapy drugs, response rates climb to 71% to 90%.
Most dogs tolerate Palladia reasonably well, though side effects are common at mild levels. The most frequent issues are vomiting, diarrhea, decreased appetite, weight loss, and lethargy. Liver enzyme elevations can occur, so your vet will run regular blood work during treatment. Serious toxicity is uncommon but possible, particularly involving the liver. Dogs on Palladia plus prednisone may face a higher risk of liver problems, so that combination requires careful monitoring.
Chemotherapy Protocols
For higher-grade tumors or those that have already spread, traditional chemotherapy drugs can produce meaningful shrinkage. A combination protocol using vinblastine and lomustine achieved a 57% response rate in dogs with visible tumors, with responses lasting a median of about one year. Dogs with only microscopic residual disease after surgery had a median overall survival of 48 weeks on this protocol.
Toxicity occurred in about 54% of treated dogs, but the majority of side effects were mild. Combining vinblastine with Palladia has shown even stronger results, with response rates between 71% and 90%. The main concern with combination therapy is a drop in white blood cell counts, which requires regular blood monitoring. Most dogs maintain a good quality of life throughout treatment, though you should expect periodic vet visits for blood draws and dose adjustments.
Radiation Therapy
Radiation is particularly effective when surgery can’t achieve clean margins, meaning some tumor cells were left behind. After incomplete surgical removal, radiation combined with other treatment gives a 95% chance of local control at one year and 85% to 95% at two to five years.
For tumors that can’t be removed surgically at all, palliative radiation can still reduce their size. A typical palliative schedule involves one treatment per week under anesthesia for four weeks. When palliative radiation is combined with Palladia, about 75% of dogs respond, and half of those achieve a complete response lasting a median of 11 months. Radiation does require general anesthesia for each session, which is worth discussing with your vet if your dog has other health concerns.
Surgery Remains the Gold Standard
While this article focuses on shrinking tumors, it’s worth noting that surgery is still the most reliable way to eliminate a mast cell tumor entirely. For grade I and II tumors under 4 cm, removing the mass with 2 cm margins on all sides and one layer of tissue (fascial plane) deep results in incomplete removal rates of 0% to 10.5% and recurrence rates near 0%. The traditional recommendation of 3 cm margins is still used for larger or higher-grade tumors.
Many veterinarians use prednisone, Palladia, or other treatments to shrink a tumor before surgery, making the procedure less invasive and improving the odds of getting clean margins. This “neoadjuvant” approach is especially helpful for tumors in tricky locations like the face, legs, or near joints where tissue is tight.
Managing Histamine Release During Treatment
Mast cells are packed with histamine, and as tumors shrink, those cells can release their contents into the bloodstream. This process, called degranulation, can cause stomach ulcers, swelling, redness, and in rare cases, a dangerous allergic-type reaction. To prevent this, vets typically prescribe two types of antihistamines: an H1 blocker like diphenhydramine (the same active ingredient in Benadryl) and an H2 blocker like famotidine to protect the stomach lining.
These medications are used before surgery, during any treatment that’s actively shrinking the tumor, and sometimes for the rest of a dog’s life if the tumor can’t be fully removed. Don’t manipulate, squeeze, or repeatedly palpate a mast cell tumor at home, as physical handling can trigger degranulation.
Dietary Adjustments That May Help
Because mast cell tumors produce and store histamine, feeding a low-histamine diet can reduce the overall histamine burden in your dog’s body. In humans, it takes about four weeks on a low-histamine diet to see measurable drops in blood histamine levels. While direct canine studies are limited, the biological rationale is sound: less dietary histamine means less total histamine for an already-overloaded system to manage.
Low-histamine foods for dogs include fresh (not processed or smoked) meat and fish, eggs, leafy greens other than spinach, rice, and quinoa. Foods to avoid include aged cheeses, fermented products, dried fruits, tomatoes, spinach, strawberries, and any processed meats. Probiotics containing Lactobacillus species can also raise histamine levels and are best avoided in dogs with mast cell tumors. A low-histamine diet won’t shrink a tumor on its own, but it can reduce discomfort and complement other treatments.